Oral chemotherapy safety practices at US cancer centres: questionnaire survey. - Wikidata - wikimedia - TriplyDB

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

http://www.wikidata.org/entity/Q35648821

about

Oral antineoplastic agents: how do we care about adherence?Impact of the healthcare payment system on patient access to oral anticancer drugs: an illustration from the French and United States contexts.Protocol for the OUTREACH trial: a randomised trial comparing delivery of cancer systemic therapy in three different settings: patient's home, GP surgery and hospital day unit Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations Medication safety of five oral chemotherapies: a proactive risk assessment.Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.Safe practice and nursing care of patients receiving oral anti-cancer medicines: a position statement from UKONS.US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards Good Intentions, Uncertain Outcomes: Physician Dispensing in Offices and Clinics Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center.Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial Improving electronic oral chemotherapy prescription: can we build a safer system?A Systematic Review of Adherence to Oral Antineoplastic Therapies Interventions to promote adherence with oral agents.Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study.Improving the Safety of Oral Chemotherapy at an Academic Medical Center Oral antineoplastic handling at health care institutions in the United States: survey of nurses and pharmacists.Documentation of oral versus intravenous chemotherapy plans in patients with metastatic non-small-cell lung cancer.Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve safety.Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.Oral chemotherapy practices at Ontario cancer centres.Oral Oncolytic Agents--A Need for Research to Enhance Patient Centeredness?Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.The relationship between patient activation, confidence to self-manage side effects, and adherence to oral oncolytics: a pilot study with Michigan oncology practices.Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.Improving pharmacist knowledge of oral chemotherapy in the community.Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.Do patients on oral chemotherapy have sufficient knowledge for optimal adherence? A mixed methods study.The Effect of Structured Education to Patients Receiving Oral Agents for Cancer Treatment on Medication Adherence and Self-efficacy.Prescribing oral chemotherapy.Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center.Chemotherapy e-prescribing: opportunities and challenges.Oncology medication safety: a 3D status report 2008.

P2860

Q28082909-38ADBCE2-6452-4377-B4CE-8C1288680220 Q33847820-D9933593-D433-4D1F-9FAC-ED8834E5B0B9 Q34061023-4DD22AD4-A8AE-40E4-80DA-22BF9E5363D2 Q34418437-1A8E471B-E34B-473C-9C47-9EFD3AC08B38 Q34459685-79522F1D-4C45-40B9-986A-B7E9C5078176 Q34459756-2FCEB4E1-8A4C-4FE7-BE8E-ACCC015E974F Q35028544-F2F4ADE6-C630-4470-BC80-766F2EE5D8F0 Q35602151-CCA67ADF-BCAA-433D-9D78-AA1986FC0867 Q35695924-4D0AA9EA-8358-4C98-9937-A607B120F79E Q36164705-11A98AF9-60E6-4209-9CDE-6F92C923F674 Q36196272-FEB3F1BE-E542-42E9-9D7B-AFC4ED725B42 Q36279167-2516FCF9-6BC9-46C3-AAAE-4671BBDC8B5A Q36406122-20FD4B35-0FB1-4B1B-806C-6470C1C8D5CF Q36673490-DC5FCB0E-CC95-4996-A21B-0E009CE2DCBD Q36841396-41A6ED58-015F-41E8-9057-D23532211571 Q37029891-AB1F06E3-41BE-424E-A82D-5DE69360D70E Q37125032-9CE9AF77-D1F5-4A4C-9CD7-0D7839A05690 Q37339975-F29EFD5F-CB1F-4B01-A7CF-C123DE11FC6F Q37628657-84BD58B1-B7AC-41DD-A215-9BD9F5AF0A6D Q37810371-E173ACDE-8BCD-4230-AA67-26B0C9A6FFD0 Q37965653-1AF44675-93C7-44C6-A0B3-1AACD5F40058 Q38042003-FFBB744A-2329-43DD-9FF1-C299D38FE503 Q38203133-D80BC5DB-5F50-4707-9E47-CF0B3A88DF7B Q38657733-DB58430D-6083-4CC3-BC8C-1742F754DA82 Q38725806-A4518B40-FCBF-4F9F-8741-9F19980F6D4A Q38767718-1172451D-AB2D-4362-BC5F-1BA7C67E1501 Q38810189-C2E4B1AC-4A91-4266-B445-A1EE275E19BF Q38931637-ADF066E2-E9A7-4292-BC84-055320DA0DBA Q39561477-ECFDC0BD-EEEE-493A-858C-A360FB0A7D49 Q40160153-5954C48A-0DD6-4814-BFCA-EDCDA64164BA Q41966885-7F912956-28E3-4820-A5F7-916F60A56024 Q42138629-2DA9E563-EC2F-4246-ADA6-7602E66D66FE Q42944289-4CC1C0B5-841D-4155-ADF0-1AAB360D48B9 Q46145766-A2FCB875-868F-4D82-ACE8-D1C236E9E381 Q49254761-308ACAF7-C6A8-49EA-ABBE-93F6BF34990F Q53208030-77ACD525-1514-4586-98A7-770223638475

P2860

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

http://www.wikidata.org/entity/Q35648821

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@ast

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@en

type

label

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@ast

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@en

prefLabel

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@ast

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@en

P1433

Q35648821-D63D5069-8EBA-4B94-B562-0C08E8EBF967

P1476

Q35648821-04A5250A-08FF-4DBB-A9EF-62AA519B06ED

P2093

Q35648821-810A48AA-1218-410B-942D-82E39A96D10B

Q35648821-864BD803-22F2-40D8-A2E0-D4E3E6F47FC3

Q35648821-A9BA5F0B-79A3-4E76-B5D3-750FAFD539DF

Q35648821-B4BA333D-1CC5-46A1-B91F-41C40D8FDE0A

Q35648821-D0949CD9-B82B-4E08-835D-E8DE03EEB4C7

Q35648821-DD37E603-6119-4DFB-8A8D-43A06CA33EC8

Q35648821-FBFE0099-4A02-4FB2-87C8-C42D4512819F

Q35648821-FD1928F1-AE34-46A7-A81A-50291F6978CD

P2860

Q35648821-0D998436-0EAF-46A2-AC38-EDF6315E77F1

Q35648821-2B6F1FA0-F0D5-4696-81F9-3A53E03BAEDF

Q35648821-748D6E6C-3A9A-413C-8372-20D94033AB12

Q35648821-7A6C5271-EE4F-4038-B070-D646798A2372

Q35648821-7CD2734E-9B49-4BDA-85F4-5D2E54788233

Q35648821-A314FC83-9103-4E4A-A8E3-E816A5F4BC85

Q35648821-ABDE1CE2-B2CE-4161-9237-59F75556820D

Q35648821-ABEFE14D-618C-419D-9243-F12321BF46AB

Q35648821-BF946AF0-C67D-4C22-B25D-781A76871D48

Q35648821-CFBBD994-6E7F-48BF-9AA8-8B775ED71DBB

P304

Q35648821-6C9A51D1-0E6D-4E1D-AB95-4940CE0A8BC7

P31

Q35648821-94EEE24D-5B8A-4B11-B613-238AEC22A9D0

P356

Q35648821-E538878F-E053-42C6-BA07-C5190C3C07DE

P407

Q35648821-6F132857-C09F-4A8F-86BB-F45DC8A35D05

P433

Q35648821-438B8A06-7976-4AAD-818B-03CFFD118C09

P478

Q35648821-4861B78E-22D8-4175-8C44-ACAF165067DE

P577

Q35648821-7FF19E99-5BE3-443A-A7F6-5B95A801794C

P5875

Q35648821-14C1E5F5-95E3-4CF7-93AF-C6A8586BE6F7

P698

Q35648821-4BB850CF-0D82-4E7F-A909-838890B98CBD

P921

Q35648821-79CDC604-5338-4703-B453-B66F4594E595

Q35648821-C4499D4C-A02D-4676-A5C5-27E4EBBBD433

P932

Q35648821-38809359-4FA9-4A56-A815-F5C2B3B6E7BC

P356

BMJ.39069.489757.55

P1433

P1476

Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

@en

P2093

Ann Partridge

http://www.w3.org/2001/XMLSchema#string

Daniela Brouillard

http://www.w3.org/2001/XMLSchema#string

Jonathan Flug

http://www.w3.org/2001/XMLSchema#string

Laurinda Morway

http://www.w3.org/2001/XMLSchema#string

Lawrence N Shulman

http://www.w3.org/2001/XMLSchema#string

Maureen Connor

http://www.w3.org/2001/XMLSchema#string

Saul N Weingart

http://www.w3.org/2001/XMLSchema#string

Sylvia Bartel

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to therapy with oral antineoplastic agents

Patient selection for oral chemotherapy.

Oral cancer treatment: developments in chemotherapy and beyond.

Safe administration of oral chemotherapy.

A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.

Patient education: the cornerstone of successful oral chemotherapy treatment.

Safety considerations and safe handling of oral chemotherapy agents.

Implementation of capecitabine (Xeloda) into a cancer centre: UK experience.

Ten simple strategies to prevent chemotherapy errors.

Oral chemotherapy: rationale and future directions.

P304

407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.39069.489757.55

http://www.w3.org/2001/XMLSchema#string

P407

P433

7590

http://www.w3.org/2001/XMLSchema#string

P478

334

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6577880

http://www.w3.org/2001/XMLSchema#string

P698

17223629

http://www.w3.org/2001/XMLSchema#string

P921

P932

1804126

http://www.w3.org/2001/XMLSchema#string